- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/625 - Salicylic acidDerivatives thereof having heterocyclic substituents, e.g. 4-salicyloylmorpholine
Patent holdings for IPC class A61K 31/625
Total number of patents in this class: 46
10-year publication summary
|
3
|
4
|
6
|
4
|
5
|
1
|
5
|
3
|
5
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan Holdings Unlimited Company | 41 |
3 |
| Smith & Nephew, Inc. | 2684 |
3 |
| Techfields Pharma Co., Ltd. | 30 |
3 |
| Eli Lilly and Company | 3738 |
2 |
| Romark Laboratories L.C. | 55 |
2 |
| Sun Pharmaceutical Industries Limited | 758 |
2 |
| The Regents of the University of California | 19608 |
1 |
| University of Florida Research Foundation, Inc. | 3968 |
1 |
| Allergan Pharmaceuticals International Limited | 243 |
1 |
| Cornell University | 3225 |
1 |
| Euticals S.p.A. | 11 |
1 |
| The George Washington University | 425 |
1 |
| The Governing Council of The University of Toronto, | 1437 |
1 |
| Hutecs Korea Pharmaceutical Co. Ltd | 3 |
1 |
| Indiana University Research and Technology Corporation | 797 |
1 |
| Kangwon National University Industry Cooperation Foundation | 23 |
1 |
| L. PERRIGO Company | 60 |
1 |
| Lupin Limited | 440 |
1 |
| Michigan State University | 79 |
1 |
| New England Medical Center Hospitals, Inc. | 14 |
1 |
| Other owners | 17 |